Spinal Tech

David Demski, CEO of Globus Medical, has resigned.

Minimally invasive spine device company Accelus is making a "strategic pivot" after it scrapped a previous deal to go public by merging with a special purpose acquisition company.

One hundred patients have been treated in an ongoing investigational device exemption clinical trial of Spineart USA's Baguera C cervical disc in the single level.

A study published in the Journal of Neurosurgery: Spine supports the effectiveness of NuVasive's Simplify cervical artificial disc at two levels compared to spinal fusion.

A spine company's $30 million investment and six more updates from spine and orthopedic device companies in the last week:

Robert Palmisano, who led Wright Medical, was added to Saluda Medical's board of directors.

AxioMed is progressing toward FDA approval for its viscoelastic for lumbar and cervical disc replacement, the devicemaker said April 19.

Johnson & Johnson saw first-quarter revenue rise 5 percent, with growth in its orthopedics sales.

SI-Bone's iFuse Bedrock Granite spine implant received a CMS new technology add-on payment.

Carlsmed raised $30 million in series B funding to ramp up commercialization of its personalized spine implants, the devicemaker said April 19.